Citations (121)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Alberto Verrotti, Renato Tambucci, Ludovica Di Francesco, Piero Pavone, Giulia Iapadre, Emma Altobelli, Sara Matricardi, Giovanni Farello & Vincenzo Belcastro. (2020) The role of polytherapy in the management of epilepsy: suggestions for rational antiepileptic drug selection. Expert Review of Neurotherapeutics 20:2, pages 167-173.
Read now
Read now
Kim Lawson. (2016) Potential drug therapies for the treatment of fibromyalgia. Expert Opinion on Investigational Drugs 25:9, pages 1071-1081.
Read now
Read now
Jose de Leon, Vincenza Santoro, Concetta D'Arrigo & Edoardo Spina. (2012) Interactions between antiepileptics and second-generation antipsychotics. Expert Opinion on Drug Metabolism & Toxicology 8:3, pages 311-334.
Read now
Read now
Matthew D Krasowski & Anton J Hopfinger. (2011) The discovery of new anesthetics by targeting GABAA receptors. Expert Opinion on Drug Discovery 6:11, pages 1187-1201.
Read now
Read now
Anna Kelemen & Péter Halász. (2010) Lacosamide for the prevention of partial onset seizures in epileptic adults. Neuropsychiatric Disease and Treatment 6, pages 465-471.
Read now
Read now
Wassim Nasreddine, Ahmad Beydoun, Samir Atweh & Bassel Abou-Khalil. (2010) Emerging drugs for partial onset seizures. Expert Opinion on Emerging Drugs 15:3, pages 415-431.
Read now
Read now
Steve S Chung. (2010) Lacosamide: new adjunctive treatment option for partial-onset seizures. Expert Opinion on Pharmacotherapy 11:9, pages 1595-1602.
Read now
Read now
Tiziana Granata, Nicola Marchi, Erin Carlton, Chaitali Ghosh, Jorge Gonzalez-Martinez, Andreas V Alexopoulos & Damir Janigro. (2009) Management of the patient with medically refractory epilepsy. Expert Review of Neurotherapeutics 9:12, pages 1791-1802.
Read now
Read now
Kai Eriksson, Tapani Keränen & Reetta Kälviäinen. (2009) Fosphenytoin. Expert Opinion on Drug Metabolism & Toxicology 5:6, pages 695-701.
Read now
Read now
Articles from other publishers (112)
Ting Zhao, Lu-hai Yu, Hui-lan Zhang, Jing Yu, Jie Feng, Ting-ting Wang, Yan Sun & Hong-jian Li. (2023) Long-term effectiveness and safety of lacosamide as adjunctive therapy in children and adolescents with refractory epilepsy: a real-world study. BMC Pediatrics 23:1.
Crossref
Crossref
Ting Zhao, Hong-jian Li, Hui-lan Zhang, Jing Yu, Jie Feng, Ting-ting Wang, Yan Sun & Lu-hai Yu. (2023) Twelve-Month Efficacy of Lacosamide Monotherapy at Maximal Dose and Tolerability for Epilepsy Treatment in Pediatric Patients: Real-World Clinical Experience. Pediatric Neurology 142, pages 23-30.
Crossref
Crossref
Clementina Lupo, Mariana Fernandes, Matteo Spanetta, Oana Elena Sarbu, Carola Carnovale, Battista Di Gioia, Fabio Placidi, Francesca Izzi, Nicola Biagio Mercuri & Claudio Liguori. (2023) The effect of lacosamide monotherapy on sleep architecture in patients with epilepsy: a preliminary evidence. Journal of Neural Transmission 130:2, pages 87-95.
Crossref
Crossref
Ashutosh Kakkad, B S Keshava, Bashir Ahmadi, GRK Sarma, Praveen Gupta, Rajaram Agarwal, Rajendra Dugani, Rajnish Kumar, Ravindra Lodha, Sanjay Varade, Hitesh Raval, Dhaval Rathod, Shohini Ghosh, Ram Gupta & Krishnaprasad K. (2023) Multi-centric Phase III, single-arm, open-label clinical study to assess clinical safety, tolerability, and efficacy of intravenous lacosamide in focal onset seizures. F1000Research 12, pages 1037.
Crossref
Crossref
Shantilal Padhiyar, Kamlesh M Jivani, Jagat Upadhyay, Tejas Patel & Bhanubhai Suhagia. (2022) Development and Validation of Stability-Indicating High-Performance Liquid Chromatography Method for Estimation of Lacosamide in Bulk and Its Pharmaceutical Dosage Form. Journal of Chromatographic Science.
Crossref
Crossref
Timofei Chernega, Jaehyoung Choi, Leonardo Salmena & Ana Cristina Andreazza. (2022) Mitochondrion-targeted RNA therapies as a potential treatment strategy for mitochondrial diseases. Molecular Therapy - Nucleic Acids 30, pages 359-377.
Crossref
Crossref
RENUKA MUNSHI & VISHWAKARMA JV. (2022) REVERSE PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-ULTRAVIOLET-BASED APPROACH FOR METHOD DEVELOPMENT AND VALIDATION OF LACOSAMIDE ESTIMATION IN HUMAN SERUM. Asian Journal of Pharmaceutical and Clinical Research, pages 98-102.
Crossref
Crossref
Adam Strzelczyk & Susanne Schubert-Bast. (2022) Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies. CNS Drugs 36:10, pages 1079-1111.
Crossref
Crossref
Fatma Fırat, Abdülkadir Bilir, Emre Atay & Hayri Demirbaş. (2022) Evaluation of anti-epileptic Lacosamide treatment on neural tube development: Chick embryo experimental model. Medical Science and Discovery 9:8, pages 475-480.
Crossref
Crossref
Shengying Lou & Sunliang Cui. (2022) Drug Treatment of Epilepsy: From Serendipitous Discovery to Evolutionary
Mechanisms. Current Medicinal Chemistry 29:19, pages 3366-3391.
Crossref
Crossref
N. Strand, C. Wie, J. Peck, M. Maita, N. Singh, J. Dumbroff, V. Tieppo Francio, M. Murphy, K. Chang, D. M. Dickerson & J. Maloney. (2022) Small Fiber Neuropathy. Current Pain and Headache Reports 26:6, pages 429-438.
Crossref
Crossref
Orhan Sumbul & Hatice Aygun. (2022) Electrocorticographic and electrocardiographic evaluation of lacosamide in a penicillin-induced status epilepticus model. Epilepsy Research 180, pages 106866.
Crossref
Crossref
R. Baron & J. Sachau. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
3473
3492
.
Takeshi Suzuki, Jun Natsume, Sumire Kumai, Yuki Maki, Hiroyuki Yamamoto, Shingo Numoto, Sho Narahara, Tetsuo Kubota, Takeshi Tsuji, Toru Kato, Keitaro Yamada, Koichi Maruyama, Akihisa Okumura, Yoshiyuki Takahashi & Hiroyuki Kidokoro. (2021) Effectiveness of lacosamide in children and young adults previously treated with other sodium channel blockers. Epilepsy & Behavior 125, pages 108397.
Crossref
Crossref
Kiran M. Kanth, Sarah Clark & Jeffrey W. Britton. 2021. Epilepsy. Epilepsy
179
215
.
Xianyu Liu, Qiyang Shen, Guo Zheng, Hu Guo, Xiaopeng Lu, Xiaoyu Wang, Xiao Yang, Zixuan Cao & Jing Chen. (2021) Gene and Phenotype Expansion of Unexplained Early Infantile Epileptic Encephalopathy. Frontiers in Neurology 12.
Crossref
Crossref
Ting Zhao, Hong-jian Li, Long Ma, Jie Feng, Ting-ting Wang, Jing Yu, Li Sun, Yan Sun & Lu-hai Yu. (2021) Safety, efficacy, and tolerability of lacosamide for the treatment of epilepsy in pediatric patients in Uygur, China. Epilepsy & Behavior 117, pages 107814.
Crossref
Crossref
Anfal Atallah S Alamrani, Ali Mohamed S Alsada, Taif Naif R Alruwaili, Jumanah Faisal I Algoufi, Ammar Khalid S Alghanmi, Abdulmajeed Hisham A Alwabel, Abdulaziz Nasser A Alahmari, Abdullah Ayed A Alshahrani & Rahmah Mohammad M Alhawiti. (2021) Effectiveness of Non-benzodiazepine Antiepileptic Drugs in Benzodiazepine-resistant Convulsive Status Epilepticus. International Journal Of Pharmaceutical And Phytopharmacological Research 11:1, pages 149-154.
Crossref
Crossref
Sofia Toniolo, Francesco Di Lorenzo, Marco Bozzali & Mahinda Yogarajah. (2020) The impact of lacosamide on mood disorders in adult patients with epilepsy: A systematic review. Epilepsy & Behavior 111, pages 107179.
Crossref
Crossref
Ghassan Hmaimess, Sandra Sabbagh, Maya Dirani, Mostafa Hotait, Adnan A. Beydoun & Wassim Nasreddine. (2020) Efficacy and tolerability of treatment with lacosamide in children: Postmarketing experience from the Middle East. Seizure 79, pages 75-79.
Crossref
Crossref
Siva Sankara Rao Yadlapalli, Naresh Kumar Katari & Surendra Babu Manabolu Surya. (2020) Determination of lacosamide in human plasma by LC–MS/MS and its application to a human pharmacokinetic study. SEPARATION SCIENCE PLUS 3:6, pages 216-224.
Crossref
Crossref
Beatriz López-Escobar, Rut Fernández-Torres, Viviana Vargas-López, Mercedes Villar-Navarro, Tatyana Rybkina, Eloy Rivas-Infante, Ayleen Hernández-Viñas, Concepción Álvarez del Vayo, José Caro-Vega, José A. Sánchez-Alcázar, Antonio González-Meneses, M. Ángel Carrión & Patricia Ybot-González. (2020) Lacosamide intake during pregnancy increases the incidence of foetal malformations and symptoms associated with schizophrenia in the offspring of mice. Scientific Reports 10:1.
Crossref
Crossref
Eswar K. Aratikatla & Asish K. Bhattacharya. (2019)
A Short Review of Synthetic Routes for the Antiepileptic Drug (
R
)-Lacosamide
. Organic Process Research & Development 24:1, pages 17-24.
Crossref
Crossref
Cecilie Johannessen Landmark & Svein I. Johannessen. 2020. Methods of Therapeutic Drug Monitoring Including Pharmacogenetics. Methods of Therapeutic Drug Monitoring Including Pharmacogenetics
225
256
.
R. Baron & J. Sachau. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
20
.
Jana Tchekalarova, Dimitrinka Atanasova, Lidia Kortenska, Nikolai Lazarov, Michaela Shishmanova-Doseva, Tzeno Galchev & Pencho Marinov. (2019) Agomelatine alleviates neuronal loss through BDNF signaling in the post-status epilepticus model induced by kainic acid in rat. Brain Research Bulletin 147, pages 22-35.
Crossref
Crossref
Andrea D Rüegger, Jeremy L Freeman & A Simon Harvey. (2019) Lacosamide in children with drug-resistant epilepsy. Journal of Paediatrics and Child Health 55:2, pages 194-198.
Crossref
Crossref
Xue Wang, Yang Yu, Rui Ma, Na Shao & Hongmei Meng. (2018) Lacosamide modulates collapsin response mediator protein 2 and inhibits mossy fiber sprouting after kainic acid-induced status epilepticus. NeuroReport 29:16, pages 1384-1390.
Crossref
Crossref
Francesco Di Lorenzo, Caterina Motta, Carlo Caltagirone, Giacomo Koch, Nicola Biagio Mercuri & Alessandro Martorana. (2018) Lacosamide in the Management of Behavioral Symptoms in Frontotemporal Dementia. Alzheimer Disease & Associated Disorders 32:4, pages 364-365.
Crossref
Crossref
Mark D. Baker, Bassel W. Abou-Khalil, Amir Arain, Pavan Tummala, Nabil J. Azar, Kevin F. Haas & Hasan H. Sonmezturk. (2018) Lacosamide efficacy and tolerability in clinical practice – Post marketing analysis from a single dedicated epilepsy center. Clinical Neurology and Neurosurgery 171, pages 179-183.
Crossref
Crossref
Maher Arabi, Taoufik Alsaadi, Wassim Nasreddine, Jasem Al-Hashel, Maya Dirani & Ahmad Beydoun. (2018) Efficacy and tolerability of treatment with lacosamide: Postmarketing experience from the Middle East region. Epilepsy & Behavior 84, pages 118-121.
Crossref
Crossref
Roberta Rudà, Alessia Pellerino, Federica Franchino, Cinzia Bertolotti, Francesco Bruno, Francesca Mo, Enrica Migliore, Gianni Ciccone & Riccardo Soffietti. (2017) Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study. Journal of Neuro-Oncology 136:1, pages 105-114.
Crossref
Crossref
Usha K. Misra, Deepanshu Dubey & Jayantee Kalita. (2017) Comparison of lacosamide versus sodium valproate in status epilepticus: A pilot study. Epilepsy & Behavior 76, pages 110-113.
Crossref
Crossref
R. Kuzmanova & I. Stefanova. (2017) Basic Mechanisms of Action of the Antiepileptic Drugs. Acta Medica Bulgarica 44:2, pages 52-58.
Crossref
Crossref
Bassel Abou-Khalil. (2017) Selecting Rational Drug Combinations in Epilepsy. CNS Drugs 31:10, pages 835-844.
Crossref
Crossref
Magdalena Bosak, Grzegorz Porębski, Agnieszka Słowik & Wojciech Turaj. (2017) Common allergies do not influence the prevalence of cutaneous hypersensitivity reactions to antiepileptic drugs. Epilepsy Research 135, pages 9-13.
Crossref
Crossref
Juan Manuel Sepúlveda-Sánchez, Antonio Conde-Moreno, Manuel Barón, Javier Pardo, Gaspar Reynés & Antonio Belenguer. (2017) Efficacy and tolerability of lacosamide for secondary epileptic seizures in patients with brain tumor: A multicenter, observational retrospective study. Oncology Letters 13:6, pages 4093-4100.
Crossref
Crossref
Kishore Sonkusare & Hanmant Barkate. (2018) Lacosamide as monotherapy in focal seizure: Literature review. International Journal of Epilepsy 04:01, pages 055-058.
Crossref
Crossref
. (2017)
Retracted
: A randomized controlled trial of lacosamide versus sodium valproate in status epilepticus
. Epilepsia 58:5, pages 919-919.
Crossref
Crossref
Philip J Wiffen, Tess E Cooper, Lauren C Heathcote, Jacqui Clinch, Richard Howard, Elliot Krane, Susan M Lord, Navil Sethna, Neil Schechter & Chantal Wood. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Sebastian Bauer, Laurent M. Willems, Esther Paule, Christine Petschow, Johann Philipp Zöllner, Felix Rosenow & Adam Strzelczyk. (2016) The efficacy of lacosamide as monotherapy and adjunctive therapy in focal epilepsy and its use in status epilepticus: clinical trial evidence and experience. Therapeutic Advances in Neurological Disorders 10:2, pages 103-126.
Crossref
Crossref
Gun-Ha KimJung Hye ByeonBaik-Lin Eun. (2017) Neuroprotective Effect of Lacosamide on Hypoxic-Ischemic Brain Injury in Neonatal Rats. Journal of Clinical Neurology 13:2, pages 138.
Crossref
Crossref
Lubos Remen, Olivier Bezençon, Lloyd Simons, Rick Gaston, Dennis Downing, John Gatfield, Catherine Roch, Melanie Kessler, Johannes Mosbacher, Thomas Pfeifer, Corinna Grisostomi, Markus Rey, Eric A. Ertel & Richard Moon. (2016) Preparation, Antiepileptic Activity, and Cardiovascular Safety of Dihydropyrazoles as Brain-Penetrant T-Type Calcium Channel Blockers. Journal of Medicinal Chemistry 59:18, pages 8398-8411.
Crossref
Crossref
A. V. Lebedeva, S. G. Burd, O. V. Belyaev, P. N. Vlasov, M. Yu. Dorofeeva, A. M. Ismailov, M. Ya. Kissin, I. Yu. Kovaleva, N. Y. Koroleva, L. V. Lipatova, K. Yu. Mukhin, Y. V. Solomatin, A. V. Chervyakov, R. G. Shikhkerimov, O. A. Pylaeva & N. V. Freidkova. (2016) Russian experience of lacosamide (vimpat) usage in treatment of uncontrolled focal epilepsy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 116:9. Vyp. 2, pages 74.
Crossref
Crossref
Victor Biton, Antonio Gil-Nagel, Jouko Isojarvi, Pamela Doty, David Hebert & Nathan B. Fountain. (2015) Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials. Epilepsy & Behavior 52, pages 119-127.
Crossref
Crossref
Willi Cawello. (2015) Clinical Pharmacokinetic and Pharmacodynamic Profile of Lacosamide. Clinical Pharmacokinetics 54:9, pages 901-914.
Crossref
Crossref
Pratima Gulati, Patricia Cannell, Twinkle Ghia, Lewis Bint, Peter Walsh, Soumya Ghosh & Lakshmi Nagarajan. (2015) Lacosamide as adjunctive therapy in treatment-resistant epilepsy in childhood. Journal of Paediatrics and Child Health 51:8, pages 794-797.
Crossref
Crossref
Yuvraj Garg & Satyendra Kumar Pandey. (2015)
An Enantioselective Approach to Functionalized Amino Acids: Total Synthesis of Antiepileptic Drug (
R
)-Lacosamide
. The Journal of Organic Chemistry 80:8, pages 4201-4203.
Crossref
Crossref
Sarah M. Wilson & Rajesh Khanna. (2014) Specific Binding of Lacosamide to Collapsin Response Mediator Protein 2 (CRMP2) and Direct Impairment of its Canonical Function: Implications for the Therapeutic Potential of Lacosamide. Molecular Neurobiology 51:2, pages 599-609.
Crossref
Crossref
Vanessa Paquette, Celia Culley, Erica D. Greanya & Mary H.H. Ensom. (2015) Lacosamide as adjunctive therapy in refractory epilepsy in adults: A systematic review. Seizure 25, pages 1-17.
Crossref
Crossref
William Rosenfeld, Nathan B. Fountain, Gintaras Kaubrys, Elinor Ben-Menachem, Cindy McShea, Jouko Isojarvi & Pamela Doty. (2014) Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years. Epilepsy & Behavior 41, pages 164-170.
Crossref
Crossref
Willi Cawello, Armel Stockis, Jens-Otto Andreas & Svetlana Dimova. (2014) Advances in epilepsy treatment: lacosamide pharmacokinetic profile. Annals of the New York Academy of Sciences 1329:1, pages 18-32.
Crossref
Crossref
Steve S Chung. (2014) Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate. Clinical Investigation 4:9, pages 839-846.
Crossref
Crossref
Zhi-Yuan Wang, Peng-Mei Lv, Zhen-Hong Yuan, Wen Luo & Shu-Na Liu. (2014) An efficient chemoenzymatic method to prepare optically active O-methyl-d-serine. Tetrahedron 70:39, pages 6991-6994.
Crossref
Crossref
Sofia Markoula, Rute Teotonio, Neville Ratnaraj, John S. Duncan, Josemir W. Sander & Philip N. Patsalos. (2014) Lacosamide Serum Concentrations in Adult Patients With Epilepsy. Therapeutic Drug Monitoring 36:4, pages 494-498.
Crossref
Crossref
Sebastian Stecko. (2014) Total Synthesis of Lacosamide. The Journal of Organic Chemistry 79:13, pages 6342-6346.
Crossref
Crossref
Steve S. Chung, Toufic A. Fakhoury, R. Edward Hogan, Venkatesh N. Nagaraddi, Ilan Blatt, Balduin Lawson, Stephan Arnold, Bob Anders, Annie M. Clark, Dawn Laine, R. Shawn Meadows & Mark B. Halvorsen. (2014)
Once‐daily
USL
255 as adjunctive treatment of partial‐onset seizures: Randomized phase
III
study
. Epilepsia 55:7, pages 1077-1087.
Crossref
Crossref
Jon Soo Kim, Hunmin Kim, Byung Chan Lim, Jong-Hee Chae, Jieun Choi, Ki Joong Kim, Yong Seung Hwang & Hee Hwang. (2014) Lacosamide as an adjunctive therapy in pediatric patients with refractory focal epilepsy. Brain and Development 36:6, pages 510-515.
Crossref
Crossref
Jae Soon Ahn, Kang Min Kim, Dae Sik Nam, Kyoung Un Kang, Peter S. Choi & Seo Young Jeong. (2014) Preparation of Lacosamide Sustained-release Tablets and Their Pharmacokinetics in Beagles and Mini-pigs. Bulletin of the Korean Chemical Society 35:2, pages 557-561.
Crossref
Crossref
Manuela Gellert, Simone Venz, Jessica Mitlöhner, Catherine Cott, Eva-Maria Hanschmann & Christopher Horst Lillig. (2013) Identification of a Dithiol-disulfide Switch in Collapsin Response Mediator Protein 2 (CRMP2) That Is Toggled in a Model of Neuronal Differentiation. Journal of Biological Chemistry 288:49, pages 35117-35125.
Crossref
Crossref
Nurcan Üçeyler, Claudia Sommer, Brian Walitt & Winfried Häuser. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Willi Cawello, Uwe Fuhr, Ursula Hering, Haidar Maatouk & Atef Halabi. (2013) Impact of Impaired Renal Function on the Pharmacokinetics of the Antiepileptic Drug Lacosamide. Clinical Pharmacokinetics 52:10, pages 897-906.
Crossref
Crossref
Aatif M. Husain. (2013) Treatment of Recurrent Electrographic Nonconvulsive Seizures (TRENdS) Study. Epilepsia 54:s6, pages 84-88.
Crossref
Crossref
Vladimir Shvarts & Steve Chung. (2013) Epilepsy, Antiseizure Therapy, and Sleep Cycle Parameters. Epilepsy Research and Treatment 2013, pages 1-8.
Crossref
Crossref
Sonja C. Sawh, Jennifer J. Newman, Santosh Deshpande & Philip M. Jones. (2013) Lacosamide adjunctive therapy for partial-onset seizures: a meta-analysis. PeerJ 1, pages e114.
Crossref
Crossref
Bo Wang, Hana Dawson, Haichen Wang, Dawn Kernagis, Brad J. Kolls, Lucy Yao & Daniel T. Laskowitz. (2012) Lacosamide Improves Outcome in a Murine Model of Traumatic Brain Injury. Neurocritical Care 19:1, pages 125-134.
Crossref
Crossref
Philip J Wiffen, Sheena Derry, R Andrew Moore, Dominic Aldington, Peter Cole, Andrew S C Rice, Michael PT Lunn, Katri Hamunen & Eija A Kalso. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Marlon G. Saria, Courtney Corle, Jethro HuJeremy D. RudnickSurasak PhuphanichMaciej M. MrugalaLaura K. CrewDaniela A. BotaBeverly Dan Fu, Ryan Y. Kim, Tiffany Brown, Homira FeelyJoanne Brechlin, Bradley D. Brown, Jan Drappatz, Patrick Y. Wen, Clark C. ChenBob CarterJong Woo Lee & Santosh Kesari. (2013) Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors. Journal of Neurosurgery 118:6, pages 1183-1187.
Crossref
Crossref
Daniel Ikeda & E. Antonio Chiocca. (2013) Editorial: Tumor and antiepileptic drugs. Journal of Neurosurgery 118:6, pages 1181-1182.
Crossref
Crossref
J. T. Kamel, M. A. DeGruyter, W. J. D'Souza & M. J. Cook. (2013) Clinical experience with using lacosamide for the treatment of epilepsy in a tertiary centre. Acta Neurologica Scandinavica 127:3, pages 149-153.
Crossref
Crossref
Willi Cawello, Hilmar Boekens & Rainer Bonn. (2012) Absorption, disposition, metabolic fate and elimination of the anti-epileptic drug lacosamide in humans: mass balance following intravenous and oral administration. European Journal of Drug Metabolism and Pharmacokinetics 37:4, pages 241-248.
Crossref
Crossref
Willi Cawello & Rainer Bonn. (2013) No Pharmacokinetic Interaction Between Lacosamide and Valproic Acid in Healthy Volunteers. The Journal of Clinical Pharmacology 52:11, pages 1739-1748.
Crossref
Crossref
Otilia Obreja, Michael Hirth, Brian Turnquist, Roman Rukwied, Matthias Ringkamp & Martin Schmelz. (2012) The Differential Effects of Two Sodium Channel Modulators on the Conductive Properties of C-Fibers in Pig Skin In Vivo. Anesthesia & Analgesia 115:3, pages 560-571.
Crossref
Crossref
Bernhard J. Steinhoff. (2012) Spezifische Wirkmechanismen gegen epileptische Anfälle. DNP - Der Neurologe und Psychiater 13:9, pages 53-59.
Crossref
Crossref
Cecilie Johannessen Landmark, Svein I. Johannessen & Torbjörn Tomson. (2012) Host factors affecting antiepileptic drug delivery—Pharmacokinetic variability. Advanced Drug Delivery Reviews 64:10, pages 896-910.
Crossref
Crossref
Danièle Bentué-Ferrer, Olivier Tribut & Marie-Clémence Verdier. (2012) Suivi thérapeutique pharmacologique du lacosamide. Therapies 67:2, pages 151-155.
Crossref
Crossref
Carl E. Stafstrom & Jong M. Rho. 2012. Swaiman's Pediatric Neurology. Swaiman's Pediatric Neurology
711
726
.
Matthew Luke. 2012. Therapeutic Drug Monitoring. Therapeutic Drug Monitoring
243
267
.
Jose de Leon. 2012. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities
139
153
.
David W. McCandlessDavid W. McCandless. 2012. Epilepsy. Epilepsy
167
181
.
David W. McCandlessDavid W. McCandless. 2012. Epilepsy. Epilepsy
153
166
.
Steve S. Chung, Kristen Kelly & Courtney Schusse. (2011) New and Emerging Treatments for Epilepsy: Review of Clinical Studies of Lacosamide, Eslicarbazepine Acetate, Ezogabine, Rufinamide, Perampanel, and Electrical Stimulation Therapy. Journal of Epilepsy Research 1:2, pages 35-46.
Crossref
Crossref
Lars BräutigamLena Dorothee Schütte, José Rodrigo Godoy, Timour Prozorovski, Manuela Gellert, Giselbert HauptmannArne HolmgrenChristopher Horst Lillig & Carsten Berndt. (2011) Vertebrate-specific glutaredoxin is essential for brain development. Proceedings of the National Academy of Sciences 108:51, pages 20532-20537.
Crossref
Crossref
Jacklyn A. Harris & Julie A. Murphy. (2011) Lacosamide and Epilepsy. CNS Neuroscience & Therapeutics 17:6, pages 678-682.
Crossref
Crossref
Tae-Sung Koo, Soo-Jin Kim, Dong-Jin Ha, Myoungki Baek & Hongsik Moon. (2011) Pharmacokinetics, brain distribution, and plasma protein binding of the antiepileptic drug lacosamide in rats. Archives of Pharmacal Research 34:12, pages 2059-2064.
Crossref
Crossref
C Kestelyn, M Lastelle, N Higuet, S Dell’Aiera, L Staelens, P Boulanger, H Boekens & S Smith. (2011) A simple HPLC–UV method for the determination of lacosamide in human plasma. Bioanalysis 3:22, pages 2515-2522.
Crossref
Crossref
M. Maschio, L. Dinapoli, M. Mingoia, F. Sperati, A. Pace, A. Pompili, C. M. Carapella, A. Vidiri & P. Muti. (2011) Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability. Journal of Neurology 258:11, pages 2100-2104.
Crossref
Crossref
R Andrew Moore, Sheena Derry & Leslie Hearn. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Martin J. Brodie, Athanasios Covanis, Antonio Gil-Nagel, Holger Lerche, Emilio Perucca, Graeme J. Sills & H. Steve White. (2011) Antiepileptic drug therapy: Does mechanism of action matter?. Epilepsy & Behavior 21:4, pages 331-341.
Crossref
Crossref
Jeffrey W. Britton & Julie Cunningham. 2011. Adult Epilepsy. Adult Epilepsy
131
169
.
M. Gavatha, I. Ioannou & A.S. Papavasiliou. (2011) Efficacy and tolerability of oral lacosamide as adjunctive therapy in pediatric patients with pharmacoresistant focal epilepsy. Epilepsy & Behavior 20:4, pages 691-693.
Crossref
Crossref
Leo L.K. Chen, Zulfi Haneef, Andrew Dorsch, Inna Keselman & John M. Stern. (2011) Successful treatment of refractory simple motor status epilepticus with lacosamide and levetiracetam. Seizure 20:3, pages 263-265.
Crossref
Crossref
M. Z. Koubeissi, C. L. Mayor, B. Estephan, S. Rashid & N. J. Azar. (2011) Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus. Acta Neurologica Scandinavica 123:2, pages 142-146.
Crossref
Crossref
Steve S Chung. (2011) Lacosamide as a new add-on therapy for the treatment of partial-onset seizures. Clinical Investigation 1:1, pages 119-124.
Crossref
Crossref
Yuying Wang & Rajesh Khanna. (2011) Voltage-gated calcium channels are not affected by the novel anti-epileptic drug lacosamide. Translational Neuroscience 2:1.
Crossref
Crossref
Steve Chung, Elinor Ben-Menachem, Michael R. Sperling, William Rosenfeld, Nathan B. Fountain, Selim Benbadis, David Hebert, Jouko Isojärvi & Pamela Doty. (2010) Examining the Clinical Utility of Lacosamide. CNS Drugs 24:12, pages 1041-1054.
Crossref
Crossref
Antonella Cuzzola, Edoardo Ferlazzo, Domenico Italiano, Rocco Salvatore Calabrò, Placido Bramanti & Pierre Genton. (2010) Does lacosamide aggravate Lennox–Gastaut syndrome? Report on three consecutive cases. Epilepsy & Behavior 19:4, pages 650-651.
Crossref
Crossref
Martin J. Brodie. (2010) Antiepileptic drug therapy the story so far. Seizure 19:10, pages 650-655.
Crossref
Crossref
Vikram C. Prabhu, Ahmad Khaldi, Kevin P. Barton, Edward Melian, Michael J. Schneck, Margaret J. Primeau & John M. Lee. (2010) Management of Diffuse Low-Grade Cerebral Gliomas. Neurologic Clinics 28:4, pages 1037-1059.
Crossref
Crossref
Matthew H Wong & Nathan B Fountain. (2010) Lacosamide for the treatment of partial-onset seizures. Therapy 7:5, pages 459-465.
Crossref
Crossref
Norbert Galldiks, Lars Timmermann, Gereon Rudolf Fink & Lothar Burghaus. (2010) Posthypoxic Myoclonus (Lance-Adams Syndrome) Treated With Lacosamide. Clinical Neuropharmacology 33:4, pages 216-217.
Crossref
Crossref
Matthew D. Krasowski. (2010) Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications. Pharmaceuticals 3:6, pages 1909-1935.
Crossref
Crossref
Willi Cawello, Brunhild Nickel & Andrea Eggert‐Formella. (2013) No Pharmacokinetic Interaction Between Lacosamide and Carbamazepine in Healthy Volunteers. The Journal of Clinical Pharmacology 50:4, pages 459-471.
Crossref
Crossref
Carl E Stafstrom. (2010) Mechanisms of action of antiepileptic drugs: the search for synergy. Current Opinion in Neurology 23:2, pages 157-163.
Crossref
Crossref
Steve S. Chung. (2010) New treatment option for partial-onset seizures: efficacy and safety of lacosamide. Therapeutic Advances in Neurological Disorders 3:2, pages 77-83.
Crossref
Crossref
Christian Tilz, Roland Resch, Thomas Hofer & Christian Eggers. (2010) Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide. Epilepsia 51:2, pages 316-317.
Crossref
Crossref
Claudia Temperini, Alessio Innocenti, Andrea Scozzafava, Seppo Parkkila & Claudiu T. Supuran. (2009) The Coumarin-Binding Site in Carbonic Anhydrase Accommodates Structurally Diverse Inhibitors: The Antiepileptic Lacosamide As an Example and Lead Molecule for Novel Classes of Carbonic Anhydrase Inhibitors. Journal of Medicinal Chemistry 53:2, pages 850-854.
Crossref
Crossref
Victor Biton. 2010. Atlas of Epilepsies. Atlas of Epilepsies
1761
1765
.
C P PanayiotopoulosC P Panayiotopoulos. 2010. A Clinical Guide to Epileptic Syndromes and their Treatment. A Clinical Guide to Epileptic Syndromes and their Treatment
565
620
.
C P PanayiotopoulosC P Panayiotopoulos. 2010. A Clinical Guide to Epileptic Syndromes and their Treatment. A Clinical Guide to Epileptic Syndromes and their Treatment
435
496
.
Jacklyn A Harris & Julie A Murphy. (2009) Lacosamide: An Adjunctive Agent for Partial-Onset Seizures and Potential Therapy for Neuropathic Pain. Annals of Pharmacotherapy 43:11, pages 1809-1817.
Crossref
Crossref
Bassel W. Abou-Khalil. (2009) Lacosamide: What Can be Expected from the Next New Antiepileptic Drug?. Epilepsy Currents 9:5, pages 133-134.
Crossref
Crossref